Skip to main content

Advertisement

SpringerLink
Log in

Adipocytokines in Normal and Complicated Pregnancies

  • Reviews
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Human pregnancy is characterized by insulin resistance, traditionally attributed to the effects of placental hormones. Normal pregnancy—induced insulin resistance is further enhanced in pregnancy complications, associated with disturbed placental function, such as gestational diabetes mellitus, preeclampsia, and intrauterine growth restriction. Compelling evidence suggests that these pregnancy disorders are associated with future development of maternal metabolic syndrome. However, the pathogenetic mechanisms underlying the association between abnormal placental development, insulin resistance, and maternal metabolic syndrome are not fully understood. A large body of evidence has recently supported the role of adipose tissue in the regulation of insulin resistance in both nonpregnant and pregnant participants. In this respect, adipocytokines, which are adipocyte-derived hormones, have been implicated in the regulation of maternal metabolism and gestational insulin resistance. Adipocytokines, including leptin, adiponectin, tumor necrosis factor α, interleukin 6, as well as the newly discovered resistin, visfatin, and apelin, are also known to be produced within the intrauterine environment. However, data concerning the pattern of adipocytokines secretion in normal and complicated pregnancies are still limited and partially contradictory. Given the importance of adipose tissue and its hormones in terms of adequate metabolic control and energy homeostasis, we present a review of published data related to the role of adipocytokines in pregnancy, especially in relation to pregnancy complications. Focus will be placed on the functions and other potential roles of the novel adipocytokines resistin, visfatin, and apelin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991;165(6 pt 1):1667–1672.

    Article  CAS  PubMed  Google Scholar 

  2. Clark CM Jr, Qui C, Amerman B, et al. Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care. 1997;20(5):867–871.

    Article  PubMed  Google Scholar 

  3. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88(6):2393–2398.

    Article  CAS  PubMed  Google Scholar 

  4. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986;93(10): 1049–1059.

    Article  CAS  PubMed  Google Scholar 

  5. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr. 2003;133(suppl 2): 1674S–1683S.

    Article  CAS  PubMed  Google Scholar 

  6. Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis. 2004;175(2):189–202.

    Article  CAS  PubMed  Google Scholar 

  7. Berends AL, de Groot CJ, Sijbrands EJ, et al. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension. 2008;51(4):1034–1041.

    Article  CAS  PubMed  Google Scholar 

  8. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol. 2000;96(6):950–955.

    CAS  PubMed  Google Scholar 

  9. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–1594.

    Article  CAS  PubMed  Google Scholar 

  10. Brodsky D, Christou H. Current concepts in intrauterine growth restriction. J Intensive Care Med. 2004;19(6):307–319.

    Article  PubMed  Google Scholar 

  11. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988;67(2):341–347.

    Article  CAS  PubMed  Google Scholar 

  12. Catalano PM, Roman-Drago NM, Amini SB, Sims EA. Longitudinal changes in body composition and energy balance in lean women with normal and abnormal glucose tolerance in pregnancy. Am J Obstet Gynecol. 1998;179(1):156–165.

    Article  CAS  PubMed  Google Scholar 

  13. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia. 2003;46(12):1594–1603.

    Article  CAS  PubMed  Google Scholar 

  14. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006;64(4):355–365.

    CAS  Google Scholar 

  15. Masuzaki H, Ogawa Y, Sagawa N, et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med. 1997;3(9):1029–1033.

    Article  CAS  PubMed  Google Scholar 

  16. Chen J, Tan B, Karteris E, et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia. 2006;49(6):1292–1302.

    Article  CAS  PubMed  Google Scholar 

  17. Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol. 1991;139(2):327–335.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Kameda T, Matsuzaki N, Sawai K, et al. Production of interleukin-6 by normal human trophoblast. Placenta. 1990;11(3):205–213.

    Article  CAS  PubMed  Google Scholar 

  19. Yura S, Sagawa N, Itoh H, et al. Resistin is expressed in the human placenta. J Clin Endocrinol Metab. 2003;88(3): 1394–1397.

    Article  PubMed  Google Scholar 

  20. Ognjanovic S, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol. 2002;187(4):1051–1058.

    Article  CAS  PubMed  Google Scholar 

  21. Cobellis L, De Falco M, Mastrogiacomo A, et al. Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol and Histopathol. 2007;22(1):1–8.

    CAS  Google Scholar 

  22. Ategbo JM, Grissa O, Yessoufou A, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab. 2006;91(10):4137–4143.

    Article  CAS  PubMed  Google Scholar 

  23. Lea RG, Howe D, Hannah LT, Bonneau O, Hunter L, Hoggard N. Placental leptin in normal, diabetic and fetal growth-retarded pregnancies. Mol Hum Reprod. 2000;6(8):763–769.

    Article  CAS  PubMed  Google Scholar 

  24. Haugen F, Ranheim T, Harsem NK, Lips E, Staff AC, Drevon CA. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am J Physiol Endocrinol Metab. 2006;290(2): E326–E333.

    Article  CAS  PubMed  Google Scholar 

  25. Lappas M, Yee K, Permezel M, Rice GE. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol. 2005;186(3):457–465.

    Article  CAS  PubMed  Google Scholar 

  26. Cortelazzi D, Corbetta S, Ronzoni S, et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol. 2007;66(3):447–453.

    Article  CAS  Google Scholar 

  27. Briana DD, Boutsikou M, Baka S, et al. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth. Neonatology. 2008;93(3):153–157.

    Article  PubMed  Google Scholar 

  28. Malamitsi-Puchner A, Briana DD, Boutsikou M, Kouskouni E, Hassiakos D, Gourgiotis D. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics. 2007;119(6):E1314–E1318.

    Article  PubMed  Google Scholar 

  29. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–432.

    Article  CAS  PubMed  Google Scholar 

  30. Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol. 2000;143(3):293–311.

    Article  CAS  PubMed  Google Scholar 

  31. Zimmet P, Boyko EJ, Collier GR, de Courten M. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann N Y Acad Sci. 1999;892:25–44.

    Article  CAS  PubMed  Google Scholar 

  32. Sennello JA, Fayad R, Morris AM, et al. Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin. Endocrinology. 2005;146(5):2157–2164.

    Article  CAS  PubMed  Google Scholar 

  33. Sattar N, Greer IA, Pirwani I, Gibson J, Wallace AM. Leptin levels in pregnancy: marker for fat accumulation and mobilization? Acta Obstet Gynecol Scand. 1998;77(3):278–283.

    Article  CAS  PubMed  Google Scholar 

  34. Butte NF, Hopkinson JM, Nicolson MA. Leptin in human reproduction: serum leptin levels in pregnant and lactating women. J Clin Endocrinol Metab. 1997;82(2):585–589.

    Article  CAS  PubMed  Google Scholar 

  35. Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol. 1998;178(5):1010–1015.

    Article  CAS  PubMed  Google Scholar 

  36. Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, Mercer JG. Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc Natl Acad Sci USA. 1997;94(20):11073–11078.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Henson M, Swan K, O’Neil JS. Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term. Obstet Gynecol. 1998;92(6):1020–1028.

    CAS  PubMed  Google Scholar 

  38. Linnemann K, Malek A, Sager R, Blum WF, Schneider H, Fusch C. Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab. 2000;85(11):4298–4301.

    CAS  PubMed  Google Scholar 

  39. Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol. 2006;194(6):1537–1545.

    Article  CAS  Google Scholar 

  40. Nuamah MA, Yura S, Sagawa N, et al. Significant increase in maternal plasma leptin concentration in induced delivery: a possible contribution of pro-inflammatory cytokines to placental leptin secretion. Endocr J. 2004;51(2):177–187.

    Article  CAS  PubMed  Google Scholar 

  41. Sagawa N, Yura S, Itoh H, et al. Possible role of placental leptin in pregnancy: a review. Endocrine. 2002;19(1):65–71.

    Article  CAS  PubMed  Google Scholar 

  42. Schulz LC, Widmaier EP. The effect of leptin on mouse trophoblast cell invasion. Biol Reprod. 2004;71(6):1963–1967.

    Article  CAS  PubMed  Google Scholar 

  43. Schulz LC, Townsend K, Kunz TH, Widmaier EP. Inhibition of trophoblast invasiveness in vitro by immunoneutralization of leptin in the bat, Myotis lucifugus (Chiroptera). Gen Comp Endocrinol. 2007;150(1):59–65.

    Article  CAS  PubMed  Google Scholar 

  44. Cseh K, Baranyi E, Melczer Z, et al. The pathophysiological influence of leptin and tumor necrosis factor system on maternal insulin resistance: negative correlations with anthropometric parameters of neonates in gestational diabetes. Gynecol Endocrinol. 2002;16(6):453–460.

    Article  CAS  PubMed  Google Scholar 

  45. Kautzky-Willer A, Pacini G, Tura A, et al. Increased plasma leptin in gestational diabetes. Diabetologia. 2001;44(2): 164–172.

    Article  CAS  PubMed  Google Scholar 

  46. Simmons D, Breier BH. Fetal overnutrition in polynesian pregnancies and in gestational diabetes may lead to dysregulation of the adipoinsular axis in offspring. Diabetes Care. 2002;25(9):1539–1544.

    Article  PubMed  Google Scholar 

  47. McLachlan KA, O’Neal D, Jenkins A, Alford FP. Do adiponectin, TNF alpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev. 2006;22(2):131–138.

    Article  CAS  PubMed  Google Scholar 

  48. Festa A, Shnawa N, Krugluger W, Hopmeier P, Schernthaner G, Haffner SM. Relative hypoleptinaemia in women with mild gestational diabetes mellitus. Diabet Med. 1999;16(8):656–662.

    Article  CAS  PubMed  Google Scholar 

  49. Lepercq J, Cauzac M, Lahlou N, et al. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes. 1998;47(5):847–850.

    Article  CAS  PubMed  Google Scholar 

  50. Mise H, Sagawa N, Matsumoto T, et al. Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. J Clin Endocrinol Metab. 1998;83(9): 3225–3229.

    CAS  PubMed  Google Scholar 

  51. Li RH, Poon SC, Yu MY, Wong YF. Expression of placental leptin and leptin receptors in preeclampsia. Int J Gynecol Pathol. 2004;23(4):378–385.

    Article  PubMed  Google Scholar 

  52. Lepercq J, Guerre-Millo M, Andre J, Cauzac M, Hauguel-de Mouzon S. Leptin: a potential marker of placental insufficiency. Gynecol Obstet Invest. 2003;55(3):151–155.

    Article  CAS  PubMed  Google Scholar 

  53. McCarthy JF, Misra DN, Roberts JM. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol. 1999;180(3 pt 1):731–736.

    Article  CAS  PubMed  Google Scholar 

  54. Laivuori H, Kaaja R, Koistinen H, et al. Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. Metabolism. 2000;49(2):259–263.

    Article  CAS  PubMed  Google Scholar 

  55. Laivuori H, Gallaher MJ, Collura L, et al. Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia. Mol Hum Reprod. 2006;12(9):551–556.

    Article  CAS  PubMed  Google Scholar 

  56. Teppa RJ, Ness RB, Crombleholme WR, Roberts JM. Free leptin is increased in normal pregnancy and further increased in preeclampsia. Metabolism. 2000;49(8):1043–1048.

    Article  CAS  PubMed  Google Scholar 

  57. Ouyang Y, Chen H, Chen H. Reduced plasma adiponectin and elevated leptin in pre-eclampsia. Int J Gynaecol Obstet. 2007;98(2):110–114.

    Article  CAS  PubMed  Google Scholar 

  58. Chappell LC, Seed PT, Briley A, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol. 2002;187(1):127–136.

    Article  PubMed  Google Scholar 

  59. Hendler I, Blackwell SC, Mehta SH, et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol. 2005;193(3 pt 2):979–983.

    Article  CAS  PubMed  Google Scholar 

  60. Nakatsukasa H, Masuyama H, Takamoto N, Hiramatsu Y. Circulating leptin and angiogenic factors in preeclampsia patients. Endocr J. 2008;55(3):565–573.

    Article  CAS  PubMed  Google Scholar 

  61. Bartha JL, Romero-Carmona R, Escobar-Llompart M, Comino-Delgado R. The relationships between leptin and inflammatory cytokines in women with pre-eclampsia. BJOG. 2001;108(12):1272–1276.

    CAS  PubMed  Google Scholar 

  62. Anim-Nyame N, Sooranna SR, Steer PJ, Johnson MR. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod. 2000;15(9):2033–2036.

    Article  CAS  PubMed  Google Scholar 

  63. Poston L. Leptin and preeclampsia. Semin Reprod Med. 2002;20(2):131–138.

    Article  CAS  PubMed  Google Scholar 

  64. Tommaselli GA, Pighetti M, Nasti A, et al. Serum leptin levels and uterine Doppler flow velocimetry at 20 weeks’ gestation as markers for the development of pre-eclampsia. Gynecol Endocrinol. 2004;19(3):160–165.

    Article  CAS  PubMed  Google Scholar 

  65. Laml T, Preyer O, Hartmann BW, Ruecklinger E, Soeregi G, Wagenbichler P. Decreased maternal serum leptin in pregnancies complicated by preeclampsia. J Soc Gynecol Investig. 2001;8(2):89–93.

    Article  CAS  PubMed  Google Scholar 

  66. Clausen T, Djurovic S, Reseland JE, Berg K, Drevon CA, Henriksen T. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation? Placenta. 2002;23(5):380–385.

    Article  CAS  PubMed  Google Scholar 

  67. Martinez-Abundis E, Gonzalez-Ortiz M, Pascoe-Gonzalez S. Serum leptin levels and the severity of preeclampsia. Arch Gynecol Obstet. 2000;264(2):71–73.

    Article  CAS  PubMed  Google Scholar 

  68. Bodary PF, Westrick RJ, Wickenheiser KJ, Shen Y, Eitzman DT. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA. 2002;287(13): 1706–1709.

    Article  CAS  PubMed  Google Scholar 

  69. Takahashi N, Waelput W, Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med. 1999;189(1):207–212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science. 1998;281(5383):1683–1686.

    Article  CAS  PubMed  Google Scholar 

  71. Catov JM, Patrick TE, Powers RW, Ness RB, Harger G, Roberts JM. Maternal leptin across pregnancy in women with small-for-gestational-age infants. Am J Obstet Gynecol. 2007;196(6):558e1–558e8.

    Article  CAS  Google Scholar 

  72. Yildiz L, Avci B, Ingec M. Umbilical cord and maternal blood leptin concentrations in intrauterine growth retardation. Clin Chem Lab Med. 2002;40(11):1114–1117.

    Article  CAS  PubMed  Google Scholar 

  73. Karowicz-Bilinska A. Leptin concentration in women with normal pregnancy and intrauterine growth retardation. Ginekol Pol. 2004;75(1):10–14.

    PubMed  Google Scholar 

  74. Ben X, Qin Y, Wu S, Zhang W, Cai W. Placental leptin correlates with intrauterine fetal growth and development. Chin Med J. 2001;114(6):636–639.

    CAS  PubMed  Google Scholar 

  75. Kyriakakou M, Malamitsi-Puchner A, Militsi H, et al. Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates and their mothers. Eur J Endocrinol. 2008;158(3):343–348.

    Article  CAS  PubMed  Google Scholar 

  76. Mise H, Yura S, Itoh H, et al. The relationship between maternal plasma leptin levels and fetal growth restriction. Endocr J. 2007;54(6):945–951.

    Article  CAS  PubMed  Google Scholar 

  77. Pighetti M, Tommaselli GA, D’Elia A, et al. Maternal serum and umbilical cord blood leptin concentrations with fetal growth restriction. Obstet Gynecol. 2003;102(3):535–543.

    CAS  PubMed  Google Scholar 

  78. Verhaeghe J, van Bree R, van Herck E. Maternal body size and birth weight: can insulin or adipokines do better? Metabolism. 2006;55(3):339–344.

    Article  CAS  PubMed  Google Scholar 

  79. Leroy P, Dessolin S, Villageois P, et al. Expression of ob gene in adipose cells. Regulation by insulin. J Biol Chem. 1996;271(5):2365–2368.

    Article  CAS  PubMed  Google Scholar 

  80. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, Guerre-Millo M. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem. 2002;277(45):42953–42957.

    Article  CAS  PubMed  Google Scholar 

  81. Kingdom JC. In vivo assessment of failed trophoblastic invasion of the spiral arteries in pre-eclampsia. Br J Obstet Gynaecol. 1999;106(12):1328–1329.

    Article  CAS  PubMed  Google Scholar 

  82. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003;26(8):2442–2450.

    Article  CAS  PubMed  Google Scholar 

  83. Wiecek A, Adamczak M, Chudek J. Adiponectin-an adipokine with unique metabolic properties. Nephrol Dial Transplant. 2007;22(4):981–988.

    Article  CAS  PubMed  Google Scholar 

  84. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930–1935.

    Article  CAS  PubMed  Google Scholar 

  85. Schondorf T, Maiworm A, Emmison N, Forst T, Pfutzner A. Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk. Clin Lab. 2005;51(9–10):489–494.

    PubMed  Google Scholar 

  86. Struwe E, Berzl GM, Schild RL, Dotsch J. Gene expression of placental hormones regulating energy balance in small for gestational age neonates. Eur J Obstet Gynecol Reprod Biol. 2009;142(1):38–42.

    Article  CAS  PubMed  Google Scholar 

  87. Chan TF, Yuan SS, Chen HS, et al. Correlations between umbilical and maternal serum adiponectin levels and neonatal birthweights. Acta Obstet Gynecol Scand. 2004;83(2):165–169.

    Article  PubMed  Google Scholar 

  88. Mazaki-Tovi S, Kanety H, Pariente C, et al. Maternal serum adiponectin levels during human pregnancy. J Perinatol. 2007;27(2):77–81.

    Article  CAS  PubMed  Google Scholar 

  89. Kajantie E, Kaaja R, Ylikorkala O, Andersson S, Lavuori H. Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity. J Soc Gynecol Investig. 2005;12(6):433–439.

    Article  CAS  PubMed  Google Scholar 

  90. O’Sullivan AJ, Kriketos AD, Martin A, Brown MA. Serum adiponectin levels in normal and hypertensive pregnancy. Hypertens Pregnancy. 2006;25(3):193–203.

    Article  CAS  PubMed  Google Scholar 

  91. Catalano PM, Hoegh M, Minium J, et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia. 2006;49(7): 1677–1685.

    Article  CAS  PubMed  Google Scholar 

  92. Mastorakos G, Valsamakis G, Papatheodorou DC, et al. The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem. 2007;53(8):1477–1483.

    Article  CAS  PubMed  Google Scholar 

  93. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab. 2004;89(5):2306–2311.

    Article  CAS  PubMed  Google Scholar 

  94. Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knofler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol. 2004;191(6):2120–2124.

    Article  CAS  PubMed  Google Scholar 

  95. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand. 2004;83(4):341–347.

    Article  PubMed  Google Scholar 

  96. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care. 2004;27(3):799–800.

    Article  CAS  PubMed  Google Scholar 

  97. Cseh K, Baranyi E, Melczer Z, Kaszas E, Winkler G. Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care. 2004;27(1):274–275.

    Article  PubMed  Google Scholar 

  98. Tsai PJ, Yu CH, Hsu SP, et al. Maternal adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Nutrition. 2005;21(11–12):1095–1099.

    Article  CAS  PubMed  Google Scholar 

  99. Winzer C, Wagner O, Festa A, et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabet Care. 2004;27(7):1721–1727.

    Article  CAS  Google Scholar 

  100. Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor-necrosis factor-alpha. Cytokine Growth Factor Rev. 2003;14(5):447–455.

    Article  CAS  PubMed  Google Scholar 

  101. Lain KY, Daftary AR, Ness RB, Roberts JM. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol. 2008;69(3):407–411.

    Article  Google Scholar 

  102. Gao XL, Yang HX, Zhao Y. Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J. 2008;121(8): 701–705.

    Article  CAS  PubMed  Google Scholar 

  103. Georgiou HM, Lappas M, Georgiou GM, et al. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol. 2008;45(3):157–165.

    Article  CAS  PubMed  Google Scholar 

  104. Ramsay JE, Jamieson N, Greer IA, Sattar N. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension. 2003;42(5):891–894.

    Article  CAS  PubMed  Google Scholar 

  105. Naruse K, Yamasaki M, Umekage H, Sado T, Sakamoto Y, Morikawa H. Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia. J Reprod Immunol. 2005;65(1): 65–75.

    Article  CAS  PubMed  Google Scholar 

  106. D’Anna R, Baviera G, Corrado F, Giordano D, Di Benedetto A, Jasonni VM. Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders. Obstet Gynecol. 2005;106(2):340–344.

    Article  PubMed  Google Scholar 

  107. Suwaki N, Masuyama H, Nakatsukasa H, et al. Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia. Am J Obstet Gynecol. 2006;195(6):1687–1692.

    Article  CAS  PubMed  Google Scholar 

  108. Ichida K, Moriyama T, Morita H, et al. Plasma adiponectin concentrations and placental adiponectin expression in pre-eclamptic women. Gynecol Endocrinol. 2007;23(4): 238–243.

    Article  CAS  PubMed  Google Scholar 

  109. Nien JK, Mazaki-Tovi S, Romero R, et al. Adiponectin in severe preeclampsia. J Perinat Med. 2007;35(6):503–512.

    CAS  PubMed  PubMed Central  Google Scholar 

  110. Fasshauer M, Bluher M, Stumvoll M, Tonessen P, Faber R, Stepan H. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol. 2007;66(3):434–439.

    Article  CAS  Google Scholar 

  111. Odden N, Henriksen T, Holter E, Grete Skar A, Tjade T, Morkrid L. Serum adiponectin concentration prior to clinical onset of preeclampsia. Hypertens Pregnancy. 2006;25(2):129–142.

    Article  CAS  PubMed  Google Scholar 

  112. Ming F, Zhou R, Cheng WB, Tie WW. Study of adiponectin expression in placenta and its correlation with preeclampsia. Zhonghua Fu Chan Ke Za Zhi. 2008;43(2):90–93.

    CAS  PubMed  Google Scholar 

  113. Kirwan JP, Haugel-De Mouzon S, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51(7):2207–2213.

    Article  CAS  PubMed  Google Scholar 

  114. Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000;67(3):291–300.

    Article  CAS  PubMed  Google Scholar 

  115. Winkler G, Cseh K, Baranyi E, et al. Tumor necrosis factor system in insulin resistance in gestational diabetes. Diab Res Clin Pract. 2002;56(3):93–99.

    Article  CAS  Google Scholar 

  116. Montagnana M, Lippi G, Albiero A, Salvagno GL, Franchi M, Guidi GC. Serum pro-inflammatory cytokines in physiological and pre-eclamptic pregnancies. Gynecol Endocrinol. 2008;24(3):113–116.

    Article  CAS  PubMed  Google Scholar 

  117. Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med. 1992;117(10):854–866.

    Article  CAS  PubMed  Google Scholar 

  118. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 1994;84(6):937–940.

    CAS  PubMed  Google Scholar 

  119. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998;40(2):102–111.

    Article  CAS  PubMed  Google Scholar 

  120. Freeman DJ, McManus F, Brown EA, et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension. 2004;44(5):708–714.

    Article  CAS  PubMed  Google Scholar 

  121. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol. 1994;170(6):1752–1757.

    Article  CAS  PubMed  Google Scholar 

  122. Bernardi F, Guolo F, Bortolin T, Petronilho F, Dal-Pizzol F. Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia. J Obstet Gynaecol Res. 2008;34(6): 948–951.

    CAS  PubMed  Google Scholar 

  123. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1–78.

    Article  CAS  PubMed  Google Scholar 

  124. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol. 2004;164(3):1049–1061.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  125. LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension. 2005;46(4):1022–1025.

    Article  Google Scholar 

  126. LaMarca BB, Cockrell K, Sullivan E, Bennett W, Granger JP. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension. 2005;46:82–86.

    Article  CAS  Google Scholar 

  127. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997;37(3):240–249.

    Article  CAS  PubMed  Google Scholar 

  128. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, et al. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol. 1999;181(4):915–920.

    Article  CAS  PubMed  Google Scholar 

  129. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 2001;86(6):2505–2512.

    CAS  PubMed  Google Scholar 

  130. Hayashi M, Ueda Y, Yamaguchi T, et al. Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood. Am J Reprod Immunol. 2005;53(3):113–119.

    Article  CAS  PubMed  Google Scholar 

  131. Hamai Y, Fujii T, Yamashita T, et al. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol. 1997;38(2):89–93.

    Article  CAS  PubMed  Google Scholar 

  132. Serin IS, Ozcelik B, Basbug M, Kilic H, Okur D, Erez R. Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2002;100(2):143–145.

    Article  CAS  PubMed  Google Scholar 

  133. Heikkinen J, Mottonen M, Pulkki K, Lassila O, Alanen A. Cytokine levels in midtrimester amniotic fluid in normal pregnancy and in the prediction of preeclampsia. Scand J Immunol. 2001;53(3):310–314.

    Article  CAS  PubMed  Google Scholar 

  134. Haider S, Knofler M. Human tumor necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta. 2009;30(2):111–123.

    Article  CAS  PubMed  Google Scholar 

  135. Peracoli JC, Rudge MV, Peracoli MT. Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and pre-eclampsia. Am J Reprod Immunol. 2007;57(3):177–185.

    Article  CAS  PubMed  Google Scholar 

  136. Bartha JL, Romero-Carmona R, Comino-Delgado R. Inflammatory cytokines in intrauterine growth retardation. Acta Ostet Gynecol Scand. 2003;82(12):1099–1102.

    Article  Google Scholar 

  137. Seremak-Mrozikiewicz A, Dubiel M, Drews K, Gudmundsson S, Mrozikiewicz PM. TNF-alpha gene polymorphism and fetal Doppler velocimetry in intrauterine growth restriction. Neuro Endocrinol Lett. 2008;29(4): 493–499.

    CAS  PubMed  Google Scholar 

  138. Holcberg G, Huleihel M, Sapir O, et al. Increased production of tumor necrosis factor-alpha TNF-alpha by IUGR human placentae. Eur J Obstet Gynecol Reprod Biol. 2001;94(1):69–72.

    Article  CAS  PubMed  Google Scholar 

  139. Stallmach T, Hebisch G, Joller H, Kolditz P, Engelmann M. Expression pattern of cytokines in the different compartments of the feto-maternal unit under various conditions. Reprod Fertil Dev. 1995;7(6):1573–1580.

    Article  CAS  PubMed  Google Scholar 

  140. Opsjon SL, Austgulen R, Waage A. Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders. Acta Obstet Gynecol Scand. 1995;74(1):19–26.

    Article  CAS  PubMed  Google Scholar 

  141. Johnson MR, Anim-Nyame N, Johnson P, Sooranna SR, Steer PJ. Does endothelial cell activation occur with intrauterine growth restriction? BJOG. 2002;109(7):836–839.

    Article  CAS  PubMed  Google Scholar 

  142. Kilani RT, Mackova M, Davidge ST, Winkler-Lowen B, Demianczuk N, Guilbert LJ. Endogenous tumor necrosis factor alpha mediates enhanced apoptosis of cultured villous trophoblasts from intrauterine growth-restricted placentae. Reproduction. 2007;133(1):257–264.

    Article  CAS  PubMed  Google Scholar 

  143. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307–312.

    Article  CAS  PubMed  Google Scholar 

  144. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002;13(1):18–23.

    Article  CAS  PubMed  Google Scholar 

  145. Azuma K, Katsukawa F, Oguchi S, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res. 2003;11(8):997–1001.

    Article  CAS  PubMed  Google Scholar 

  146. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab. 2003;88(11):5452–5455.

    Article  CAS  PubMed  Google Scholar 

  147. Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Klimis-Zacas D, Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab. 2003;88(4): 1730–1736.

    Article  CAS  PubMed  Google Scholar 

  148. Utzschneider KM, Carr DB, Tong J, et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia. 2005;48(11):2330–2333.

    Article  CAS  PubMed  Google Scholar 

  149. Le Lay S, Boucher J, Rey A, et al. Decreased resistin expression in mice with different sensitivities to a high-fat diet. Biochem Biophys Res Commun. 2001;289(2):564–567.

    Article  CAS  PubMed  Google Scholar 

  150. Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J Physiol Endocrinol Metab. 2003;285(1):E106–E115.

    Article  CAS  PubMed  Google Scholar 

  151. Banerjee RR, Rangwala SM, Shapiro JS, et al. Regulation of fasted blood glucose by resistin. Science. 2004;303(5661): 1195–1198.

    Article  CAS  PubMed  Google Scholar 

  152. Kielstein JT, Becker B, Graf S, Brabant G, Haller H, Fliser D. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis. 2003;42(1):62–66.

    Article  CAS  PubMed  Google Scholar 

  153. Chen D, Dong M, Fang Q, He J, Wang Z, Yang X. Alterations of serum resistin in normal pregnancy and preeclampsia. Clin Sci. 2005;108(1):81–84.

    Article  CAS  Google Scholar 

  154. Nien JK, Mazaki-Tovi S, Romero R, et al. Resistin: a hormone which induces insulin resistance is increased in normal pregnancy. J Perinat Med. 2007;35(6):513–521.

    CAS  PubMed  PubMed Central  Google Scholar 

  155. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003;88(10):4848–4856.

    Article  CAS  PubMed  Google Scholar 

  156. Lee JH, Bullen JW Jr, Stoyneva VL, Mantzoros CS. Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia. Am J Physiol Endocrinol Metab. 2005;288(3): E625–632.

    Article  CAS  PubMed  Google Scholar 

  157. Chen D, Fang Q, Chai Y, Wang H, Huang H, Dong M. Serum resistin in gestational diabetes mellitus and early postpartum. Clin Endocrinol. 2007;67(2):208–211.

    Article  CAS  Google Scholar 

  158. Palik E, Baranyi E, Melczer Z, et al. Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res Clin Pract. 2007;76(3):351–357.

    Article  CAS  PubMed  Google Scholar 

  159. Megia A, Vendrell J, Gutierrez C, et al. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol. 2008;158(2):173–178.

    Article  CAS  PubMed  Google Scholar 

  160. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307(5708):426–430.

    Article  CAS  PubMed  Google Scholar 

  161. Sethi JK, Vidal-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med. 2005;11(8):344–347.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  162. Arner P. Visfatin-a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab. 2006;91(1):28–30.

    Article  CAS  PubMed  Google Scholar 

  163. Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2006;91(1):295–299.

    Article  CAS  PubMed  Google Scholar 

  164. Filippatos TD, Derdemezis CS, Gazi IF, et al. Increased plasma visfatin levels in subjects with the metabolic syndrome. Eur J Clin Invest. 2008;38(1):71–72.

    Article  CAS  PubMed  Google Scholar 

  165. Berndt J, Kloting N, Kralisch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes. 2005;54(10):2911–2916.

    Article  CAS  PubMed  Google Scholar 

  166. Pagano C, Pilon C, Olivieri M, et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab. 2006;91(8):3165–3170.

    Article  CAS  PubMed  Google Scholar 

  167. Morgan SA, Bringolf JB, Seidel ER. Visfatin expression is elevated in normal human pregnancy. Peptides. 2008;29(8):1382–1389.

    Article  CAS  PubMed  Google Scholar 

  168. Telejko B, Kuzmicki M, Zonenberg A, et al. Visfatin in gestational diabetes: Serum level and mRNA expression in fat and placental tissue. Diab Res Clin Pract. 2009;84(1):68–75.

    Article  CAS  Google Scholar 

  169. Hu W, Wang Z, Wang H, Huang H, Dong M. Serum visfatin levels in late pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand. 2008;87(4):413–418.

    Article  CAS  PubMed  Google Scholar 

  170. Rongvaux A, Shea RJ, Mulks MH, et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol. 2002;32(11):3225–3234.

    Article  CAS  PubMed  Google Scholar 

  171. Tanaka M, Nozaki M, Fukuhara A, et al. Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. Biochem Biophys Res Commun. 2007;359(2):194–201.

    Article  CAS  PubMed  Google Scholar 

  172. Josephs T, Waugh H, Kokay I, Grattan D, Thompson M. Fasting-induced adipose factor identified as a key adipokine that is up-regulated in white adipose tissue during pregnancy and lactation in the rat. J Endocrinol. 2007;194(2):305–312.

    Article  CAS  PubMed  Google Scholar 

  173. Chan TF, Chen YL, Lee CH, et al. Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Investig. 2006;13(5):364–367.

    Article  CAS  PubMed  Google Scholar 

  174. Haider DG, Handisurya A, Storka A, et al. Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care. 2007;30(7):1889–1891.

    Article  CAS  PubMed  Google Scholar 

  175. Akturk M, Altinova AE, Mert I, et al. Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester. J Endocrinol Invest. 2008;31(7):610–613.

    Article  CAS  PubMed  Google Scholar 

  176. Lewandowski KC, Stojanovic N, Press M, et al. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia. 2007;50(5):1033–1037.

    Article  CAS  PubMed  Google Scholar 

  177. Krzyzanowska K, Krugluger W, Mittermayer F, et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci. 2006;110(5):605–609.

    Article  CAS  Google Scholar 

  178. Mazaki-Tovi S, Romero R, Kusanovic JP, et al. Visfatin in human pregnancy: maternal gestational diabetes vis-a-vis neonatal birthweight. J Perinat Med. IN PRESS.

  179. Ognjanovic S, Bao S, Yamamoto SY, Garibay-Tupas J, Samal B, Bryant-Greenwood GD. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol. 2001;26(2):107–117.

    Article  CAS  PubMed  Google Scholar 

  180. Fasshauer M, Waldeyer T, Seeger J, et al. Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol. 2008;69(1):69–73.

    Article  CAS  Google Scholar 

  181. Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251(2):471–476.

    Article  CAS  PubMed  Google Scholar 

  182. De Falco M, De Luca L, Onori N, et al. Apelin expression in normal human tissues. In Vivo. 2002;16(5):333–336.

    PubMed  Google Scholar 

  183. Rayalam S, Della-Fera MA, Krieg PA, Cox CM, Robins A, Baile CA. A putative role for apelin in the etiology of obesity. Biochem Biophys Res Commun. 2008;368(3): 815–819.

    Article  CAS  PubMed  Google Scholar 

  184. Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther. 2005;107(2):198–211.

    Article  CAS  PubMed  Google Scholar 

  185. Tatemoto K, Takayama K, Zou MX. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept. 2001;99(2–3):87–92.

    Article  CAS  PubMed  Google Scholar 

  186. Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764–1771.

    Article  CAS  PubMed  Google Scholar 

  187. Daviaud D, Boucher J, Gesta S, et al. TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J. 2006;20(9):1528–1530.

    Article  CAS  PubMed  Google Scholar 

  188. Kunduzova O, Alet N, Delesque-Touchard N, et al. Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes. FASEB J. 2008;22(12):4146–4153.

    Article  CAS  PubMed  Google Scholar 

  189. Lago F, Dieguez C, Gomez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 2007;18(3–4):313–325.

    Article  CAS  PubMed  Google Scholar 

  190. Beltowski J. Apelin and visfatin: unique “beneficial” adipokines upregulated in obesity? Med Sci Monit. 2006;12(6):RA112–RA119.

    CAS  PubMed  Google Scholar 

  191. Cox CM, D’Agostino SL, Miller MK, Heimark RL, Krieg PA. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol. 2006;296(1):177–189.

    Article  CAS  PubMed  Google Scholar 

  192. Liao YM, Qiao FY. Expression of Apelin in placentas of patients with hypertensive disorders complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi. 2007;42(6):382–385.

    CAS  PubMed  Google Scholar 

  193. Malamitsi-Puchner A, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, Briana DD. Circulating apelin concentrations in mother/infant pairs at term. Acta Paediatrica. 2007;96(12):1751–1754.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neonatal Division, 2nd Department of Obstetrics and Gynecology, Athens University Medical School, 19, Soultani Street, 10682, Athens, Greece

    Despina D. Briana MD & Ariadne Malamitsi-Puchner MD

Authors
  1. Despina D. Briana MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ariadne Malamitsi-Puchner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ariadne Malamitsi-Puchner MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Briana, D.D., Malamitsi-Puchner, A. Adipocytokines in Normal and Complicated Pregnancies. Reprod. Sci. 16, 921–937 (2009). https://doi.org/10.1177/1933719109336614

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719109336614

Key words

Search

Navigation